Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	AKAP_110_C	AKAP3 SPHKAP	2.51e-04	3	172	2	IPR018292
Domain	ASD1	SHROOM3 SHROOM2	2.51e-04	3	172	2	PF08688
Domain	ASD1_dom	SHROOM3 SHROOM2	2.51e-04	3	172	2	IPR014800
Domain	ASD1	SHROOM3 SHROOM2	2.51e-04	3	172	2	PS51306
Domain	VDCC_a2/dsu	CACNA2D2 CACNA2D4	5.00e-04	4	172	2	IPR013680
Domain	Shroom_fam	SHROOM3 SHROOM2	5.00e-04	4	172	2	IPR027685
Domain	ASD2_dom	SHROOM3 SHROOM2	5.00e-04	4	172	2	IPR014799
Domain	VGCC_alpha2	CACNA2D2 CACNA2D4	5.00e-04	4	172	2	PF08473
Domain	ASD2	SHROOM3 SHROOM2	5.00e-04	4	172	2	PF08687
Domain	SPHK1-interactor_AKAP_110	AKAP3 SPHKAP	5.00e-04	4	172	2	IPR008382
Domain	AKAP_110	AKAP3 SPHKAP	5.00e-04	4	172	2	PF05716
Domain	ASD2	SHROOM3 SHROOM2	5.00e-04	4	172	2	PS51307
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ALKBH4 HSPG2 SHROOM3 ABL1 TRIO MYO10 INPP5E MEX3D C15orf39 CUL9 TEP1 KIAA2013 MAP3K5 GGA3 FASN PER2 MROH6 ZNF827 GLI1 AKAP13 MLLT6 TNFAIP3 AGRN CD276	4.74e-09	1105	183	24	35748872
Pubmed	Characterization and evolution of the novel gene family FAM90A in primates originated by multiple duplication and rearrangement events.	FAM90A19 FAM90A7 FAM90A18 FAM90A9 FAM90A10	1.86e-07	25	183	5	17684299
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SHROOM3 HDAC4 RANBP3 RAD54L2 GGA3 KIAA1671 ZNF469 POM121 FAM193A SALL1 AKAP13 MLLT6 FHIP1A	5.29e-07	430	183	13	35044719
Pubmed	Human transcription factor protein interaction networks.	SMG1 HSPG2 L3MBTL2 MRS2 TRPS1 C15orf39 CUL9 R3HDM2 ZNF217 RAD54L2 LHX8 KIAA1671 NOL4L HOXC9 SALL1 NFATC3 RECQL5 MLLT6 TAF4 TAF10 EN1 ZMYM3 TP53BP1 NPAT	5.58e-07	1429	183	24	35140242
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	WHRN MYO10 CUL9 R3HDM2 TSC1 GGA3 RUSC2 PER2 SPHKAP NAV3 VPS13B ZMYM3	1.90e-06	407	183	12	12693553
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	FBF1 TRPS1 CUL9 C16orf96 TEP1 KIAA1671 TUBGCP6 ARHGAP4 MSH6 ZNF469 ZNF827 KMT5B NAF1 SIGLEC1 TAF4 TAF10 ZMYM3 AFF4 SPATC1L TBX2	2.00e-06	1116	183	20	31753913
Pubmed	Interaction network of human early embryonic transcription factors.	HDAC4 L3MBTL2 TRPS1 C15orf39 ZNF217 RAD54L2 KIAA1671 SALL1 TAF4 ZMYM3 TBX2	2.87e-06	351	183	11	38297188
Pubmed	Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice.	HSPG2 DAG1 AGRN	4.94e-06	7	183	3	11802174
Pubmed	Analysis of the multi-copy gene family FAM90A as a copy number variant in different ethnic backgrounds.	FAM90A19 FAM90A7 FAM90A9 FAM90A10	6.07e-06	23	183	4	18602769
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	SLC37A1 BDP1 ATRN ZNF444 SHROOM3 HDAC4 TRIO NUMBL CACNA2D2 TRPS1 ARHGAP39 TEP1 SHROOM2 SSPOP KIAA1671 ZNF827 CLMN AKAP13 TAF4 ADAT2 VPS13B AFF4	1.31e-05	1489	183	22	28611215
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SHROOM3 ABL1 HDAC4 TRIO NUMBL INPP5E RANBP3 RUSC2 KIAA1671 DLC1 NFATC3 CLMN NHS AKAP13 TNFAIP3 CGNL1	1.43e-05	861	183	16	36931259
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	L3MBTL2 TRPS1 C15orf39 ZNF217 KIAA1671 FASN NOL4L FAM193A SALL1 ZMYM3 NPAT	1.49e-05	418	183	11	34709266
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	BDP1 C15orf39 CUL9 TSC1 ZNF217 RAD54L2 KIAA1671 SALL1 NFATC3 RECQL5 CGNL1 ZMYM3 TP53BP1	1.58e-05	588	183	13	38580884
Pubmed	Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	BDP1 ARHGAP39 DLC1 SPHKAP CGNL1 LNPK	1.73e-05	102	183	6	11214970
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	HSPG2 NUMBL PLEKHG4 R3HDM2 RAD54L2 TEP1 SSPOP POLR1H RINT1 POM121 MLLT6 LNX1 AGRN	2.24e-05	608	183	13	16713569
Pubmed	Agrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma.	HSPG2 AGRN	2.75e-05	2	183	2	25506919
Pubmed	The CTRB1-CTRB2 risk allele for chronic pancreatitis discovered in European populations does not contribute to disease risk variation in the Chinese population due to near allele fixation.	CTRB2 CTRB1	2.75e-05	2	183	2	28951524
Pubmed	Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis.	CTRB2 CTRB1	2.75e-05	2	183	2	28754779
Pubmed	A novel BHLHE41 variant is associated with short sleep and resistance to sleep deprivation in humans.	BHLHE41 ADRB1	2.75e-05	2	183	2	25083013
Pubmed	Differential DNA binding and transcription modulation by three T-box proteins, T, TBX1 and TBX2.	TBX1 TBX2	2.75e-05	2	183	2	11111039
Pubmed	Agrin is involved in lymphocytes activation that is mediated by alpha-dystroglycan.	DAG1 AGRN	2.75e-05	2	183	2	16394267
Pubmed	Molecular cloning and nucleotide sequence of human pancreatic prechymotrypsinogen cDNA.	CTRB2 CTRB1	2.75e-05	2	183	2	2917002
Pubmed	Genomic cloning and partial characterization of human chymotrypsinogen gene.	CTRB2 CTRB1	2.75e-05	2	183	2	8186414
Pubmed	Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response.	HDAC4 TP53BP1	2.75e-05	2	183	2	12668657
Pubmed	The nob2 mouse, a null mutation in Cacna1f: anatomical and functional abnormalities in the outer retina and their consequences on ganglion cell visual responses.	CACNA1F NYX	2.75e-05	2	183	2	16597347
Pubmed	Chymotrypsin Reduces the Severity of Secretagogue-Induced Pancreatitis in Mice.	CTRB2 CTRB1	2.75e-05	2	183	2	30076839
Pubmed	Sequencing of the complex CTRB1-CTRB2 locus in chronic pancreatitis.	CTRB2 CTRB1	2.75e-05	2	183	2	33036922
Pubmed	Genetic and functional analysis of SHROOM1-4 in a Chinese neural tube defect cohort.	SHROOM3 SHROOM2	2.75e-05	2	183	2	29423651
Pubmed	Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor.	DAG1 AGRN	2.75e-05	2	183	2	8205617
Pubmed	Evolutionary relationships between laboratory mice and subspecies of Mus musculus based on the restriction fragment length variants of the chymotrypsin gene at the Prt-2 locus.	CTRB2 CTRB1	2.75e-05	2	183	2	2565717
Pubmed	Incorporating Functional Information in Tests of Excess De Novo Mutational Load.	TRIO KMT5B	2.75e-05	2	183	2	26235986
Pubmed	Mutations in the CACNA1F and NYX genes in British CSNBX families.	CACNA1F NYX	2.75e-05	2	183	2	12552565
Pubmed	Rapamycin rescues BMP mediated midline craniosynostosis phenotype through reduction of mTOR signaling in a mouse model.	TSC1 GLI1	2.75e-05	2	183	2	30134066
Pubmed	F-box/WD Repeat-Containing Protein 5 Mediates the Ubiquitination of Apoptosis Signal-Regulating Kinase 1 and Exacerbates Nonalcoholic Steatohepatitis in Mice.	MAP3K5 FBXW5	2.75e-05	2	183	2	30703849
Pubmed	Mutation and copy number analysis of LNX1 and Numbl in nervous system tumors.	NUMBL LNX1	2.75e-05	2	183	2	18940473
Pubmed	X-Linked Congenital Stationary Night Blindness	CACNA1F NYX	2.75e-05	2	183	2	20301423
Pubmed	[Molecular cloning and identify expression of the novel human LNX gene in gliomas].	SPHKAP LNX1	2.75e-05	2	183	2	16324299
Pubmed	Altered Tbx1 gene expression is associated with abnormal oesophageal development in the adriamycin mouse model of oesophageal atresia/tracheo-oesophageal fistula.	TBX1 TBX2	2.75e-05	2	183	2	24356861
Pubmed	Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue.	DAG1 AGRN	2.75e-05	2	183	2	9417121
Pubmed	Novel mutations in CACNA1F and NYX in Dutch families with X-linked congenital stationary night blindness.	CACNA1F NYX	2.75e-05	2	183	2	15761389
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	L3MBTL2 NUMBL RANBP3 RTN4 TSC1 PFKM GGA3 KIAA1671 MSH6 FASN FAM193A CLMN NAF1 CGNL1 AFF4 TP53BP1	3.82e-05	934	183	16	33916271
Pubmed	Deletion of astroglial connexins weakens the blood-brain barrier.	HSPG2 DAG1 AGRN	5.00e-05	14	183	3	22472609
Pubmed	Blimp1 regulates development of the posterior forelimb, caudal pharyngeal arches, heart and sensory vibrissae in mice.	GLI1 TBX1 TBX2	5.00e-05	14	183	3	18039967
Pubmed	Voltage-activated calcium channel expression profiles in mouse brain and cultured hippocampal neurons.	CACNA1F CACNA2D2 CACNA2D4	6.22e-05	15	183	3	20188150
Pubmed	Differential neuronal targeting of a new and two known calcium channel β4 subunit splice variants correlates with their regulation of gene expression.	CACNA1F CACNA2D2 CACNA2D4	6.22e-05	15	183	3	24453333
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	AKAP6 CNST INPP5E DAG1 SHROOM2 LANCL2 RNF215 NOL4L CLMN GLI1 TNFAIP3 LNPK AGRN VPS13B AFF4 TP53BP1 NPAT	6.48e-05	1084	183	17	11544199
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	ABL1 L3MBTL2 TRIO MYO10 INPP5E TRPS1 CTRB2 ZNF217 FASN	7.18e-05	332	183	9	37433992
Pubmed	Patterns of laminins and integrins in the embryonic ventricular zone of the CNS.	HSPG2 DAG1 AGRN	7.63e-05	16	183	3	17948866
Pubmed	Bmp4 in limb bud mesoderm regulates digit pattern by controlling AER development.	GLI1 EN1 TBX2	7.63e-05	16	183	3	15581864
Pubmed	POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation.	POM121 POM121B	8.23e-05	3	183	2	30802453
Pubmed	Characterization of four mammalian numb protein isoforms. Identification of cytoplasmic and membrane-associated variants of the phosphotyrosine binding domain.	NUMBL LNX1	8.23e-05	3	183	2	10551880
Pubmed	B7-H3 regulates lipid metabolism of lung cancer through SREBP1-mediated expression of FASN.	FASN CD276	8.23e-05	3	183	2	27939887
Pubmed	α-Dystroglycan is essential for the induction of Egr3, a transcription factor important in muscle spindle formation.	DAG1 AGRN	8.23e-05	3	183	2	20213761
Pubmed	Conditional deletion of Tsc1 in the female reproductive tract impedes normal oviductal and uterine function by enhancing mTORC1 signaling in mice.	TSC1 PGR	8.23e-05	3	183	2	23475984
Pubmed	Nucleoporin POM121 signals TFEB-mediated autophagy via activation of SIGMAR1/sigma-1 receptor chaperone by pridopidine.	POM121 POM121B	8.23e-05	3	183	2	35507432
Pubmed	Increasing expression of dual-specificity phosphatase 12 mitigates oxygen-glucose deprivation/reoxygenation-induced neuronal apoptosis and inflammation through inactivation of the ASK1-JNK/p38 MAPK pathway.	DUSP12 MAP3K5	8.23e-05	3	183	2	38721693
Pubmed	Genetic study of pancreatic proteinase in mice (Mus musculus): linkage of the Prt-2 locus on chromosome 8.	CTRB2 CTRB1	8.23e-05	3	183	2	1016231
Pubmed	The multi zinc-finger protein Trps1 acts as a regulator of histone deacetylation during mitosis.	HDAC4 TRPS1	8.23e-05	3	183	2	23892436
Pubmed	Tyrosine kinase c-Abl couples RNA polymerase II transcription to DNA double-strand breaks.	ABL1 TP53BP1	8.23e-05	3	183	2	30668775
Pubmed	Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function.	HSPG2 DAG1	8.23e-05	3	183	2	16098969
Pubmed	Evolutionary expansion of polyaspartate motif in the activation peptide of mouse cationic trypsinogen limits autoactivation and protects against pancreatitis.	CTRB2 CTRB1	8.23e-05	3	183	2	34643096
Pubmed	Loss of chymotrypsin-like protease (CTRL) alters intrapancreatic protease activation but not pancreatitis severity in mice.	CTRB2 CTRB1	8.23e-05	3	183	2	32678161
Pubmed	Reciprocal expressions between α-dystroglycan and integrin β1, perlecan receptors, in the murine enamel organ development.	HSPG2 DAG1	8.23e-05	3	183	2	23722005
Pubmed	Cell behaviors and genetic lineages of the mesencephalon and rhombomere 1.	GLI1 EN1	8.23e-05	3	183	2	15294143
Pubmed	Secretagogue-induced pancreatitis in mice devoid of chymotrypsin.	CTRB2 CTRB1	8.23e-05	3	183	2	38981616
Pubmed	Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer.	PGR FASN	8.23e-05	3	183	2	33335078
Pubmed	α2δ-4 Is Required for the Molecular and Structural Organization of Rod and Cone Photoreceptor Synapses.	CACNA1F CACNA2D4	8.23e-05	3	183	2	29875267
Pubmed	Advanced light-entrained activity onsets and restored free-running suprachiasmatic nucleus circadian rhythms in per2/dec mutant mice.	BHLHE41 PER2	8.23e-05	3	183	2	22080784
Pubmed	Dynamics of expression patterns of AQP4, dystroglycan, agrin and matrix metalloproteinases in human glioblastoma.	DAG1 AGRN	8.23e-05	3	183	2	22307776
Pubmed	Tissue-specific interaction of Per1/2 and Dec2 in the regulation of fibroblast circadian rhythms.	BHLHE41 PER2	8.23e-05	3	183	2	23223373
Pubmed	Interaction of RIPK1 and A20 modulates MAPK signaling in murine acetaminophen toxicity.	MAP3K5 TNFAIP3	8.23e-05	3	183	2	33460648
Pubmed	Genetic study of pancreatic proteinase in mice (Mus musculus): genetic variants of trypsin and chymotrypsin.	CTRB2 CTRB1	8.23e-05	3	183	2	1008801
Pubmed	Differential expression profiles between α-dystroglycan and integrin β1 in ameloblastoma: two possible perlecan signalling pathways for cellular growth and differentiation.	HSPG2 DAG1	8.23e-05	3	183	2	21255062
Pubmed	GLI1 interferes with the DNA mismatch repair system in pancreatic cancer through BHLHE41-mediated suppression of MLH1.	BHLHE41 GLI1	8.23e-05	3	183	2	24165159
Pubmed	Spatiotemporal regulation of GLI target genes in the mammalian limb bud.	WHRN SHROOM3 SALL1 GLI1 FGFBP3 PLPPR2 TBX2	1.20e-04	207	183	7	26238476
Pubmed	FBF1 deficiency promotes beiging and healthy expansion of white adipose tissue.	FBF1 FASN GLI1	1.31e-04	19	183	3	34348145
Pubmed	Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4.	TAF1B TAF4 TAF10	1.53e-04	20	183	3	17884155
Pubmed	Cloning and sequencing of the mouse Gli2 gene: localization to the Dominant hemimelia critical region.	GLI1 EN1	1.64e-04	4	183	2	9027508
Pubmed	Molecular mechanism of transcriptional repression of AhR repressor involving ANKRA2, HDAC4, and HDAC5.	HDAC4 AHRR	1.64e-04	4	183	2	17949687
Pubmed	Role of alpha2/delta subunit in the development of morphine-induced rewarding effect and behavioral sensitization.	CACNA2D2 CACNA2D4	1.64e-04	4	183	2	19596051
Pubmed	Mammalian target of rapamycin complex 1 and cyclooxygenase 2 pathways cooperatively exacerbate endometrial cancer.	TSC1 PGR	1.64e-04	4	183	2	25058027
Pubmed	Mouse all-cone retina models of Cav1.4 synaptopathy.	CACNA1F CACNA2D4	1.64e-04	4	183	2	37181655
Pubmed	Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes.	POM121 POM121B	1.64e-04	4	183	2	17900573
Pubmed	Origin and Segmental Diversity of Spinal Inhibitory Interneurons.	HOXC9 EN1	1.64e-04	4	183	2	29307712
Pubmed	PHF19 activates hedgehog signaling and promotes tumorigenesis in hepatocellular carcinoma.	PHF19 GLI1	1.64e-04	4	183	2	34129846
Pubmed	Mutation screening of TRPM1, GRM6, NYX and CACNA1F genes in patients with congenital stationary night blindness.	CACNA1F NYX	1.64e-04	4	183	2	22735794
Pubmed	Dystroglycan is selectively associated with inhibitory GABAergic synapses but is dispensable for their differentiation.	DAG1 AGRN	1.64e-04	4	183	2	12040032
Pubmed	HDAC4 regulates satellite cell proliferation and differentiation by targeting P21 and Sharp1 genes.	BHLHE41 HDAC4	1.64e-04	4	183	2	29472596
Pubmed	Generation of Evc2/Limbin global and conditional KO mice and its roles during mineralized tissue formation.	EVC2 GLI1	1.64e-04	4	183	2	26219237
Pubmed	Adiponectin induces A20 expression in adipose tissue to confer metabolic benefit.	PER2 TNFAIP3	1.64e-04	4	183	2	25190567
Pubmed	Chondrocyte mTORC1 activation stimulates miR-483-5p via HDAC4 in osteoarthritis progression.	HDAC4 TSC1	1.64e-04	4	183	2	30145794
Pubmed	Conjugation of LG domains of agrins and perlecan to polymerizing laminin-2 promotes acetylcholine receptor clustering.	HSPG2 AGRN	1.64e-04	4	183	2	16219760
Pubmed	The Lnx family proteins function as molecular scaffolds for Numb family proteins.	NUMBL LNX1	1.64e-04	4	183	2	11922143
Pubmed	Novel ATPase of SNF2-like protein family interacts with androgen receptor and modulates androgen-dependent transcription.	RAD54L2 PGR	1.64e-04	4	183	2	12058073
Pubmed	Perlecan is recruited by dystroglycan to nodes of Ranvier and binds the clustering molecule gliomedin.	HSPG2 DAG1	1.64e-04	4	183	2	25646087
Pubmed	A new standard nomenclature for proteins related to Apx and Shroom.	SHROOM3 SHROOM2	1.64e-04	4	183	2	16615870
Pubmed	An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy.	DAG1 AGRN	1.64e-04	4	183	2	11565031
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SHROOM3 HDAC4 TRIO NUMBL TSC1 ARHGAP39 MAP3K5 SNAP91 NFATC3 ICAM5 SPHKAP TAF4 AGRN AFF4 TP53BP1	1.90e-04	963	183	15	28671696
Pubmed	The transcription regulator Lmo3 is required for the development of medial ganglionic eminence derived neurons in the external globus pallidus.	LHX8 GLI1 NPAS1	2.05e-04	22	183	3	37532091
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	IL12RB1 VWF TRIO NUMBL RTN4 TSC1 ARHGAP39 PFKM SHROOM2 LANCL2 FASN SNAP91 CLMN ICAM5 AJM1 HECW2 CGNL1 PLPPR2 DNPEP	2.10e-04	1431	183	19	37142655
Cytoband	22q13.31-q13.33	L3MBTL2 TUBGCP6	1.58e-05	2	183	2	22q13.31-q13.33
Cytoband	8p23.1	RP1L1 FAM90A19 FAM90A7 FAM90A18 FAM90A9 FAM90A10	3.81e-05	154	183	6	8p23.1
Cytoband	11q22-q23	PGR NPAT	2.35e-04	6	183	2	11q22-q23
Cytoband	Ensembl 112 genes in cytogenetic band chr8p23	RP1L1 FAM90A19 FAM90A7 FAM90A18 FAM90A9 FAM90A10	3.73e-04	234	183	6	chr8p23
Cytoband	9q34.3	INPP5E AJM1 FBXW5 RNF208	8.84e-04	106	183	4	9q34.3
Cytoband	12q13.3	R3HDM2 PFKM HOXC9	1.13e-03	51	183	3	12q13.3
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	AKAP6 AKAP3 SPHKAP AKAP13	2.74e-05	29	110	4	396
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	ARHGAP39 ARHGAP4 DLC1 ARHGAP27	2.41e-04	50	110	4	721
GeneFamily	Calcium voltage-gated channel subunits	CACNA1F CACNA2D2 CACNA2D4	5.14e-04	26	110	3	253
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	TRIO PLEKHG4 AKAP13 FGD3	6.99e-04	66	110	4	722
GeneFamily	Blood group antigens\|CD molecules\|Proteoglycans	HSPG2 AGRN	7.55e-04	7	110	2	570
CoexpressionAtlas	gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0	ALKBH4 BHLHE41 HSPG2 IBA57 SHROOM3 TMEM229A PHF19 MEX3D DUSP4 DAG1 ZNF217 FASN PER2 SNAP91 ZNF827 FBXW5 RPUSD2 MLLT6 GATD1 WDR86 CGNL1 LNX1 AGRN FHIP1A RNF208 CD276 TBX2	4.24e-06	1275	172	27	gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IL12RB1 NIBAN1 TSC1 SFT2D3 ZNF831 GATD1 WDR86 TBX1 FGD3	4.84e-08	179	179	9	6bbb32d7e582a96cb3cfc3eb911b05d518e7d5e9
ToppCell	Bronchial_Biopsy-Mesenchymal-Smooth_muscle\|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X	AKAP6 NIBAN1 VWF LGI4 KIAA1671 OLFML2A ARHGAP4 CLMN	1.38e-06	197	179	8	98f0184a09563a544f0c2d4df22c9db2fbc95019
ToppCell	facs-Marrow-KLS-18m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 LHX8 SSPOP ADRB1 ICAM5 LINGO4 NHS	3.04e-06	154	179	7	37765512dfae557b9f6eb30a29463b93682a4404
ToppCell	T_cells-TFH-like_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	WHRN EVC2 DUSP4 TRPS1 ZNF831 SLCO5A1 NHS	4.61e-06	164	179	7	b10cf59f4cc37ca6cd0ecf71d7de278cc2bdd8b5
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l9\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLC37A1 IL12RB1 LANCL2 ITGB7 LMAN1L COCH CTRB1	6.55e-06	173	179	7	15a77f6aac968b7a1afea4f60aedbb95b9d0f765
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF SHROOM2 KIAA1671 NOL4L CACNA2D4 ADRB1 NHS	7.33e-06	176	179	7	7292e014b8f697f0c2e9f47c48333de95cb44a69
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF SHROOM2 KIAA1671 NOL4L CACNA2D4 ADRB1 NHS	7.33e-06	176	179	7	88ca2f83d8301633232735f39b0683efe49d0b86
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NIBAN1 ZNF831 OLFML2A HECW2 SPHKAP NAV3 TBX1	7.61e-06	177	179	7	c274fbdc141855ff4581d437d4997c64cc193278
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NIBAN1 ZNF831 OLFML2A HECW2 SPHKAP NAV3 TBX1	7.61e-06	177	179	7	f5e6df5cafd003bbfbb3b634ee58d0b1e2be5cc7
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NIBAN1 ZNF831 OLFML2A HECW2 SPHKAP NAV3 TBX1	7.61e-06	177	179	7	c8a51e480b978dc0ded85583261f2c892e085be8
ToppCell	droplet-Lung-nan-18m-Lymphocytic-T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL12RB1 ZNF831 SHC3 ITGB7 LINGO4 LRRN4 SPATC1L	8.19e-06	179	179	7	8ebd0c7ac99ac8194fa1a2aac88a893739a97725
ToppCell	10x5'v1-week_14-16-Lymphocytic_NK-T_NK-ILC_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	WHRN CACNA2D2 FASN AHRR SNAP91 LINGO4 TNFAIP3	8.49e-06	180	179	7	a999a6d219a8e58a8b63802ddf8c95ffaab9cfa0
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IL12RB1 ZNF831 SHC3 ITGB7 LINGO4 LRRN4 SPATC1L	8.80e-06	181	179	7	c7ad10a696d94b9ee91cd7e62761d356d5106eda
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IL12RB1 ZNF831 SHC3 ITGB7 LINGO4 LRRN4 SPATC1L	8.80e-06	181	179	7	eaa3a2c268cce527004ae656d35e037b984fb4c7
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	AKAP6 HSPG2 LGI4 GALR2 OLFML2A CILP2 SHPK	9.12e-06	182	179	7	a1c0e4090a9e7aa4941a40c817d178de144888b6
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	NIBAN1 R3HDM2 NOL4L COCH FAM193A TNFAIP3 TAF10	9.45e-06	183	179	7	807d64deaf4e50dccf6f831f88578a6d903c1421
ToppCell	Control-Epithelial-ATII\|World / Disease state, Lineage and Cell class	SHROOM3 CACNA2D2 SHC3 FASN DLC1 CGNL1 FHIP1A	1.05e-05	186	179	7	f4b6e401e19a71beddc73d8a1e08359f7c4025cf
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SHROOM3 CACNA2D2 SHC3 FASN DLC1 CGNL1 FHIP1A	1.25e-05	191	179	7	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-7\|TCGA-Stomach / Sample_Type by Project: Shred V9	AKAP6 NIBAN1 VXN PGR SNAP91 FRRS1L	1.27e-05	127	179	6	5e4d110cc6e68cd8fc7a4771a65e6f8cd83e7721
ToppCell	droplet-Heart-HEART-1m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF PHF19 MSH6 SALL1 CGNL1 AGRN TBX1	1.34e-05	193	179	7	d0a5f212f8e8a13dbbe3e41df92548ef82eef70b
ToppCell	facs-Pancreas-Exocrine-3m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 TMEM229A OLFML2A CLMN CGNL1 CTRB1 AGRN	1.34e-05	193	179	7	c3161a14a40323a58aa202c8a1d6ea0e9c2b9814
ToppCell	Control-Lymphoid-T\|Lymphoid / Disease state, Lineage and Cell class	NIBAN1 DUSP4 TRPS1 ZNF831 MAP3K5 AKAP13 TNFAIP3	1.43e-05	195	179	7	6687e579582d7a239bee80846de0cf827a6f6a62
ToppCell	Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Man1a_(Man1a)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	IL12RB1 SSPOP LY6G6F CACNA2D4 SPOCD1	1.78e-05	80	179	5	d42b72ef822f731ff5ff1d04216e91f414c5556e
ToppCell	Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Man1a_(Man1a)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	IL12RB1 SSPOP LY6G6F CACNA2D4 SPOCD1	1.78e-05	80	179	5	d3ee8fc9b2cb47ee476f4cd8b9fcba14cb9ca759
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Trm_Tgd\|lymph-node_spleen / Manually curated celltypes from each tissue	DUSP4 VWCE TEP1 ADRB1 RPUSD2 WDR86	3.90e-05	155	179	6	b0e456c4915076e1d38282e116a6eb3230ae80dc
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 FAM163A KLF14 HECW2 SPHKAP RNF208	3.90e-05	155	179	6	8fdda4e3657ac56188ae88ed3caf145f4d9d1567
ToppCell	3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PHF19 MCIDAS VXN CACNA2D4 PLPPR2 FGD3	4.82e-05	161	179	6	3a5f2877e3b29463a3a6da05009b0ab8747b4c47
ToppCell	TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-1\|TCGA-Kidney / Sample_Type by Project: Shred V9	FAM163A VWF CCDC85A OLFML2A PER2 HECW2	4.82e-05	161	179	6	6cacae4a759ace763597ee394cff498dc5d96f74
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC37A1 ZNF831 ITGB7 ARHGAP4 TNFAIP3 FGD3	4.99e-05	162	179	6	58fe827198c172eeaa26273b0fad7991a718b0bf
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Sla\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	VXN PTPRU ZNF831 MAP3K5 NLRP6 DLC1	4.99e-05	162	179	6	4d13c271b4f63cf32980e5643b5d5951165fe8b5
ToppCell	droplet-Marrow-BM-30m-Lymphocytic-plasma_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DUSP12 LHX8 TEP1 OLFML2A SIGLEC1 SPATC1L	5.34e-05	164	179	6	758e85e2f5e7236b345e16c78344d5e0bf17d8dc
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-BM_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DUSP12 ARHGAP39 LHX8 GALR2 FGFBP3 LINGO4	5.71e-05	166	179	6	aa2df07eff323ded751ced8938af08223d7f2029
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DUSP12 ARHGAP39 LHX8 GALR2 FGFBP3 LINGO4	5.71e-05	166	179	6	695298a94d62b8adab083900003ec636fbaae5d9
ToppCell	normal_Lung-T/NK_cells-Exhausted_CD8+_T\|T/NK_cells / Location, Cell class and cell subclass	NIBAN1 DUSP4 ASCL5 NAV3 NHS TNFAIP3	6.11e-05	168	179	6	76b49463895cdef27c90f831c6246bcb92b9761b
ToppCell	E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	HSPG2 VWF DUSP4 CUL9 RECQL5 VPS13B	6.95e-05	172	179	6	3b9be685fcd1634498a603b692f5ac6ddd0de176
ToppCell	COVID-19-kidney-REN+Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CTRB2 MAP3K5 DLC1 CLMN NHS TBX2	7.41e-05	174	179	6	8393f0b43c767839c1630bcb952d62b42efc788d
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NIBAN1 ASCL5 DLC1 EN1 SPOCD1 NPAS1	7.90e-05	176	179	6	8b5c2fb7e5e551df658b1d5fc7f607a27bab00d5
ToppCell	P15-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	IBA57 FBF1 LGI4 LY6G6F SHPK NHS	7.90e-05	176	179	6	792f414f5092aba14260b8e16378e793a822498e
ToppCell	Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D175\|Adult / Lineage, Cell type, age group and donor	IBA57 VWF PLEKHG4 KIAA1671 NOL4L NAV3	8.15e-05	177	179	6	c9f269765c7d5d29caab75910e51645606ed562e
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HSPG2 SHROOM3 MAP3K5 CGNL1 FHIP1A FGD3	8.15e-05	177	179	6	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_2\|356C / Donor, Lineage, Cell class and subclass (all cells)	IL12RB1 NIBAN1 DUSP4 FBF1 FRRS1L ADAT2	8.40e-05	178	179	6	8b939659f713eea50a1a6e28b571f680ca0b4c12
ToppCell	COVID-19-kidney-REN+Pericyte\|kidney / Disease (COVID-19 only), tissue and cell type	CTRB2 MAP3K5 PGR DLC1 HECW2 TBX2	8.67e-05	179	179	6	342c1cc4444f51b8dcb30d3adc98285a25669c6e
ToppCell	P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	AKAP6 BHLHE41 NIBAN1 ARHGAP39 LGI4 SHPK	8.94e-05	180	179	6	1e819c5c87704ec6535dfeaae56561895e239d07
ToppCell	Control-Endothelial_cells-Capillary_endothelial_cells\|Control / group, cell type (main and fine annotations)	SHROOM2 CCDC85A KIAA1671 HECW2 LNX1 TBX2	8.94e-05	180	179	6	b043f9ffb9a4cd427a15bebb86a711c7b08866e8
ToppCell	droplet-Lung-nan-18m-Lymphocytic-Ly6g5b+_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL12RB1 ZNF831 SHC3 LINGO4 LRRN4 SPATC1L	8.94e-05	180	179	6	81c7086399256260e59424b7410feec514ce8027
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1F HSPG2 SHROOM3 CGNL1 AGRN FHIP1A	9.21e-05	181	179	6	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	droplet-Kidney-nan-3m-Mesenchymal-podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LGI4 SLCO5A1 AHRR COCH NAV3 WDR86	9.21e-05	181	179	6	0b1e7335648823b1d83bdfa878ccd44efe7bba9a
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUMBL MEX3D SLCO5A1 AJM1 C4BPB CD276	9.21e-05	181	179	6	7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HSPG2 VWF MYO10 CCDC85A KIAA1671 HECW2	9.49e-05	182	179	6	0346f81bbb1f309f3e9d063b20547d548d09472c
ToppCell	droplet-Limb_Muscle-nan-21m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM229A VXN DAG1 ARHGAP39 LGI4 SHPK	9.49e-05	182	179	6	a512863304fad80acaab60a8c6107eb7c9cbac99
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	AKAP6 NIBAN1 DLC1 CLMN NHS TBX2	9.78e-05	183	179	6	818fd886e0188091310825f9145fa53328f2c979
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	SHROOM3 CACNA2D2 FASN DLC1 CGNL1 FHIP1A	9.78e-05	183	179	6	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	Adult-Mesenchymal-pericyte_cell-D122\|Adult / Lineage, Cell type, age group and donor	MYO10 DUSP4 LGI4 CLMN CTRB1 TBX2	9.78e-05	183	179	6	fc31a43a637423cb3bb9aa184a3a889a0b9aaea6
ToppCell	Control-Myeloid-DC1\|Myeloid / Condition, Lineage and Cell class	HSPG2 DUSP4 SLCO5A1 ZNF827 WDR86 FHIP1A	1.01e-04	184	179	6	b5c1f57f0356969cfb0e1dac764684fc5583bc04
ToppCell	droplet-Lung-nan-21m-Epithelial-club_cell_of_bronchiole\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BHLHE41 SHROOM2 PGR LNX1 FHIP1A RNF208	1.01e-04	184	179	6	7cc3b9bba1f600b40b02fe2456b5d007dbf9fa37
ToppCell	droplet-Lung-nan-21m-Epithelial-Club_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BHLHE41 SHROOM2 PGR LNX1 FHIP1A RNF208	1.01e-04	184	179	6	53b71c4ac86dc5e42763b8f64fbc917177531017
ToppCell	IPF-Epithelial-ATII\|IPF / Disease state, Lineage and Cell class	SHROOM3 CACNA2D2 FASN DLC1 CGNL1 FHIP1A	1.04e-04	185	179	6	563b4e6d92bb5d77a3829556116a8e99aebac615
ToppCell	343B-Fibroblasts-Fibroblast-E-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	BDP1 TSC1 PTPRU GGA3 TUBGCP6 GLI1	1.04e-04	185	179	6	1b8e3ddb91797f84e4b15d2457b0c008e5be50db
ToppCell	343B-Fibroblasts-Fibroblast-E\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	BDP1 TSC1 PTPRU GGA3 TUBGCP6 GLI1	1.04e-04	185	179	6	02cbf492bc40abebaa93a3a208888afae72fbe06
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1F HSPG2 VWF MYO10 KIAA1671 ARHGAP27	1.04e-04	185	179	6	602536a3308a848f106adcb0a83530997440c8f4
ToppCell	PBMC-Control-cDC_10\|Control / Compartment, Disease Groups and Clusters	BHLHE41 DUSP4 SLCO5A1 ICAM5 WDR86 TBX1	1.04e-04	185	179	6	4b5a7450fed912f340da16065c1e65d626dbe8d1
ToppCell	IPF-Epithelial-ATII\|World / Disease state, Lineage and Cell class	SHROOM3 CACNA2D2 FASN DLC1 CGNL1 FHIP1A	1.07e-04	186	179	6	6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947
ToppCell	PCW_05-06-Endothelial-Endothelial_mature-lymphatic\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	NIBAN1 VWF KIAA1671 NAV3 ARHGAP27 TBX1	1.07e-04	186	179	6	86b218a400f9c64f92b050f00b49f09647b17437
ToppCell	PCW_05-06-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	NIBAN1 VWF KIAA1671 NAV3 ARHGAP27 TBX1	1.07e-04	186	179	6	f51c76b1c3c6c49e0ebc9a913d8413e0b6a04d80
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	HSPG2 SHROOM3 SHC3 ICAM5 AGRN FHIP1A	1.10e-04	187	179	6	4ae7465174e0295d2c3b614b321a3b2f514dd22a
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM229A OLFML2A CLMN CGNL1 CTRB1 AGRN	1.10e-04	187	179	6	9aa411ae9b5a923378a5daebb8bb2fc2613f2510
ToppCell	15-Distal-Mesenchymal-Pericyte\|Distal / Age, Tissue, Lineage and Cell class	BHLHE41 DUSP4 KLF14 LGI4 TMEM266 NPAS1	1.13e-04	188	179	6	4963382e54aac06bf5047c7d725393db70667ee7
ToppCell	COPD-Epithelial-ATII\|COPD / Disease state, Lineage and Cell class	SHROOM3 CACNA2D2 FASN DLC1 CGNL1 FHIP1A	1.13e-04	188	179	6	eb6d79d733b53f64ca615bb777c64ed456866549
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HSPG2 VWF MYO10 CCDC85A KIAA1671 HECW2	1.17e-04	189	179	6	db09d591b885ce2bc9e353f08b6694e2192582e1
ToppCell	IPF-Lymphoid-T_Regulatory\|Lymphoid / Disease state, Lineage and Cell class	CNST DUSP4 TRPS1 CUL9 MAP3K5 ADAT2	1.17e-04	189	179	6	7a260485c2a7c743c14d048e5e480ae0a9b8e32c
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SHROOM2 KIAA1671 ADRB1 HECW2 LNX1 TBX2	1.17e-04	189	179	6	b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	AKAP6 NIBAN1 LGI4 SLCO5A1 DLC1 TBX2	1.17e-04	189	179	6	127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	HSPG2 VWF SHROOM2 KIAA1671 DLC1 CGNL1	1.17e-04	189	179	6	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	AKAP6 NIBAN1 LGI4 SLCO5A1 DLC1 TBX2	1.17e-04	189	179	6	2cfb4d12f75678d1619f4743838a0e954bd57761
ToppCell	COVID-19-Heart-EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	VWF CCDC85A DLC1 CLMN NHS TBX2	1.20e-04	190	179	6	a21653bfb7bafbc273f94fa7c13bfb48cf8fd562
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF CCDC85A KIAA1671 ADRB1 HECW2 ARHGAP27	1.20e-04	190	179	6	106ea0bb7b99c697ffc5443d72343df2484250c7
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SHROOM3 CACNA2D2 SHC3 DLC1 CGNL1 FHIP1A	1.24e-04	191	179	6	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	HSPG2 VWF MYO10 CCDC85A KIAA1671 LNX1	1.24e-04	191	179	6	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	SHROOM3 CACNA2D2 SHC3 DLC1 CGNL1 FHIP1A	1.27e-04	192	179	6	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	SHROOM3 CACNA2D2 SHC3 FASN DLC1 FHIP1A	1.27e-04	192	179	6	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	RA-09._Endothelium_I\|RA / Chamber and Cluster_Paper	HSPG2 VWF MYO10 CCDC85A KIAA1671 LNX1	1.27e-04	192	179	6	8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc
ToppCell	3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HSPG2 NIBAN1 VWF MYO10 KIAA1671 HECW2	1.27e-04	192	179	6	1f35efb0765e05f7f9c881849953bef3965be25a
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SHROOM3 CACNA2D2 SHC3 FASN DLC1 FHIP1A	1.31e-04	193	179	6	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	368C-Fibroblasts-Fibroblast-K_(Pericytes)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	AKAP6 NIBAN1 LGI4 KIAA1671 CLMN TBX2	1.31e-04	193	179	6	5260ac95a15cc43a19909badad0c7e3854da920d
ToppCell	facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WHRN SMG1 MSH6 NFATC3 KMT5B LINGO4	1.31e-04	193	179	6	a6a864644e1b80b7417ea0a27281e79068a3fd3d
ToppCell	368C-Fibroblasts-Fibroblast-K_(Pericytes)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	AKAP6 NIBAN1 LGI4 KIAA1671 CLMN TBX2	1.31e-04	193	179	6	5ec917931b438dd0e7fb03eb6af459d3ef6b84ba
ToppCell	11.5-Airway-Immune-Hematopoietic,_T_Cells\|Airway / Age, Tissue, Lineage and Cell class	IL12RB1 ITGB7 CACNA2D4 LINGO4 TNFAIP3 FGD3	1.31e-04	193	179	6	7c14bc481ed38378b9e6a85f768a1e526c5997e6
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SHROOM3 CACNA2D2 SHC3 FASN DLC1 FHIP1A	1.31e-04	193	179	6	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	cellseq2-Epithelial-Epithelial_Alveolar-AT2-AT2\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NUMBL CACNA2D2 FBF1 RAD54L2 DLC1 RPUSD2	1.35e-04	194	179	6	df835578d86a49ae5af5632152fbab9548c0a448
ToppCell	cellseq2-Epithelial-Epithelial_Alveolar\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NUMBL CACNA2D2 FBF1 RAD54L2 DLC1 RPUSD2	1.35e-04	194	179	6	0715f2d55f4a6d2edda1b3dc52f12d25ce59eb10
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	HSPG2 VWF SHROOM2 KIAA1671 SALL1 CGNL1	1.35e-04	194	179	6	b6cc849fa08599bff9839ef382d190cc964e273e
ToppCell	cellseq2-Epithelial-Epithelial_Alveolar-AT2\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NUMBL CACNA2D2 FBF1 RAD54L2 DLC1 RPUSD2	1.35e-04	194	179	6	a4f7cd507eba40985d82635bbae28c7f5703f883
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4\|TCGA-Prostate / Sample_Type by Project: Shred V9	EVC2 PHF19 RUSC2 OLFML2A ZNF469 NHS	1.38e-04	195	179	6	5562665dd3beb70e2358aa32611a337bef5731c1
ToppCell	wk_15-18-Endothelial-Blood_vessel_endothelial-Late_cap\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	HSPG2 VWF CCDC85A KIAA1671 ADRB1 HECW2	1.38e-04	195	179	6	dfc5da514fb34a2c318a5c4c61f44049fa43960e
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CACNA2D2 SHC3 FASN DLC1 AKAP13 CGNL1	1.42e-04	196	179	6	7e5addaa844e66f8160e05858c341866a80aed23
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CACNA2D2 SHC3 FASN DLC1 AKAP13 CGNL1	1.42e-04	196	179	6	82b117be41f2e7d677a42d2a5198726eeccb16d0
ToppCell	COPD-Lymphoid-T\|Lymphoid / Disease state, Lineage and Cell class	NIBAN1 DUSP4 TRPS1 ZNF831 MAP3K5 TNFAIP3	1.42e-04	196	179	6	c9bdd505c3ab380ed7b272aa518df31a0a706a06
ToppCell	3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HSPG2 NIBAN1 VWF MYO10 KIAA1671 CGNL1	1.46e-04	197	179	6	98e34e8612f111bb667a574de1faaa785d318ca4
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 VWF KIAA1671 OLFML2A HECW2 NAV3	1.46e-04	197	179	6	cd509e49bbdbf991cc5913960ff3ef275ad40628
ToppCell	Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	EVC2 ZNF217 HOXC9 GLI1 NAV3 CRB2	1.46e-04	197	179	6	31c8d6e565bbdc37843ce871fe91845b0cc18a9f
Drug	Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A	ALKBH4 BHLHE41 WHRN HSPG2 TRIO RAD54L2 ARHGAP4 FASN PLCB3 AGRN TBX2	3.71e-07	193	178	11	3262_UP
Drug	Idoxuridine [54-42-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A	ALKBH4 HSPG2 DAG1 C15orf39 PTPRU RAD54L2 OLFML2A ARHGAP4 RPUSD2 PLCB3 PLPPR2	3.90e-07	194	178	11	1480_DN
Drug	Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; MCF7; HT_HG-U133A	WHRN IL12RB1 TRIO MYO10 CUL9 RUSC2 ARHGAP4 PER2 AKAP13 DNPEP	3.30e-06	195	178	10	4686_DN
Drug	Diazoxide [364-98-7]; Down 200; 17.4uM; PC3; HT_HG-U133A	SLC37A1 TRAF3IP2 TRIO CUL9 RUSC2 OLFML2A NFATC3 CIAO3 PLCB3 PLPPR2	3.62e-06	197	178	10	5810_DN
Drug	Alfaxalone [23930-19-0]; Down 200; 12uM; MCF7; HT_HG-U133A	ZNF444 CACNA2D2 RANBP3 DAG1 MAP3K5 NFATC3 CLMN PLCB3 PLPPR2	2.39e-05	195	178	9	6514_DN
Drug	Carbarsone [121-59-5]; Down 200; 15.4uM; PC3; HT_HG-U133A	WHRN IL12RB1 HSPG2 ZNF444 TRIO C15orf39 ITGB7 PLCB3 DNPEP	2.92e-05	200	178	9	3991_DN
Drug	pyrenebutyl methylphosphonofluoridate	CTRB2 FASN CTRB1	3.81e-05	9	178	3	CID000125653
Drug	delta(E)Phe	CTRB2 NHS CTRB1	3.81e-05	9	178	3	CID000133830
Drug	BOCPheONP	CTRB2 CTRB1	6.08e-05	2	178	2	CID000111308
Drug	dg 4	DAG1 TBX1	6.08e-05	2	178	2	CID000218188
Drug	MPM-06	CTRB2 CTRB1	6.08e-05	2	178	2	CID000161546
Drug	NSC-374899	CTRB2 CTRB1	6.08e-05	2	178	2	CID000435726
Drug	methylbenzenebutanoate	CTRB2 CTRB1	6.08e-05	2	178	2	CID000281254
Drug	Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu	CTRB2 CTRB1	6.08e-05	2	178	2	CID004418081
Drug	c189	CTRB2 CTRB1	6.08e-05	2	178	2	CID000248048
Drug	dansyl-D-arginine methyl ester	CTRB2 CTRB1	6.08e-05	2	178	2	CID000191369
Drug	methyl 6-phenylhexanoate	CTRB2 CTRB1	6.08e-05	2	178	2	CID011820300
Drug	5-aminotetrazole	CTRB2 CTRB1	6.08e-05	2	178	2	CID000020467
Drug	2-bromoisobutyric acid	CTRB2 CTRB1	6.08e-05	2	178	2	CID000074924
Drug	p-toluamidine	CTRB2 CTRB1	6.08e-05	2	178	2	CID000122753
Drug	N-acetyl-alpha-azaphenylalanine phenyl ester	CTRB2 CTRB1	6.08e-05	2	178	2	CID000191275
Drug	isobutyl sulfide	CTRB2 CTRB1	6.08e-05	2	178	2	CID000011607
Drug	Parthenolide [20554-84-1]; Down 200; 16.2uM; PC3; HT_HG-U133A	BHLHE41 TRAF3IP2 ATRN ZNF444 DUSP4 SHROOM2 PER2 TNFAIP3	8.55e-05	179	178	8	5105_DN
Drug	estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A	WHRN PGR RUSC2 DLC1 NFATC3 RECQL5 AGRN VPS13B	1.39e-04	192	178	8	5238_UP
Drug	fluorescein dilaurate	DUSP4 CTRB2 CTRB1	1.61e-04	14	178	3	CID000081743
Drug	Buspirone hydrochloride [33386-08-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A	ZNF444 INPP5E RANBP3 PTPRU RINT1 NFATC3 AFF4 TBX2	1.66e-04	197	178	8	5343_DN
Drug	Spiramycin [8025-81-8]; Down 200; 4.8uM; HL60; HT_HG-U133A	BHLHE41 IL12RB1 ZNF444 INPP5E DLC1 RECQL5 PLCB3 AGRN	1.66e-04	197	178	8	2558_DN
Drug	Furosemide [54-31-9]; Up 200; 12uM; MCF7; HT_HG-U133A	BHLHE41 HSPG2 NIBAN1 TRIO ITGB7 RUSC2 OLFML2A PER2	1.78e-04	199	178	8	6841_UP
Drug	N-acetylbenzotriazole	CTRB2 CTRB1	1.81e-04	3	178	2	CID000087784
Drug	photophor	CTRB2 CTRB1	1.81e-04	3	178	2	CID000014780
Drug	dibutyl iodomethaneboronate	CTRB2 CTRB1	1.81e-04	3	178	2	CID000098591
Drug	zinc;dipicolinate	CTRB2 CTRB1	1.81e-04	3	178	2	CID004309911
Drug	2-oxobut-3-ynoate	CTRB2 CTRB1	1.81e-04	3	178	2	CID000171547
Drug	AFMeq	CTRB2 CTRB1	1.81e-04	3	178	2	CID000194069
Drug	Bz-Cti-otbu	CTRB2 CTRB1	1.81e-04	3	178	2	CID006452691
Drug	n-(2-oxoethyl)benzamide	CTRB2 CTRB1	1.81e-04	3	178	2	CID000188995
Drug	AC1L49DM	CTRB2 CTRB1	1.81e-04	3	178	2	CID000152933
Drug	c140	CTRB2 CTRB1	1.81e-04	3	178	2	CID002783250
Drug	Benzamidomethaneboronic acid	CTRB2 CTRB1	1.81e-04	3	178	2	CID000127677
Drug	phenyl hippurate	CTRB2 CTRB1	1.81e-04	3	178	2	CID000076323
Drug	FK-386	CTRB2 CTRB1	1.81e-04	3	178	2	CID000135044
Drug	FK-375	CTRB2 CTRB1	1.81e-04	3	178	2	CID000135042
Drug	carbostyril-124	CTRB2 CTRB1	1.81e-04	3	178	2	CID000088277
Drug	N-trifluoroacetyl-4-fluorophenylalanine	CTRB2 CTRB1	1.81e-04	3	178	2	CID000328214
Drug	C18 4	CTRB2 CTRB1	1.81e-04	3	178	2	CID000077248
Drug	taraxastane	CTRB2 CTRB1	1.81e-04	3	178	2	CID006429404
Drug	Phe-phe-ome	CTRB2 CTRB1	1.81e-04	3	178	2	CID000151728
Drug	phenylethaneboronic acid	CTRB2 CTRB1	1.81e-04	3	178	2	CID000065389
Drug	3-amino-2-pyridone	CTRB2 CTRB1	1.81e-04	3	178	2	CID000322353
Drug	ASA-BMPA	CTRB2 CTRB1	1.81e-04	3	178	2	CID003035649
Drug	p-nitrophenyl benzoate	CTRB2 CTRB1	1.81e-04	3	178	2	CID000070396
Drug	Z-Phe-OMe	CTRB2 CTRB1	1.81e-04	3	178	2	CID003082435
Drug	3-methylcoumarin	CTRB2 CTRB1	1.81e-04	3	178	2	CID000017130
Drug	2-propyl methylphosphonochloridate	CTRB2 CTRB1	1.81e-04	3	178	2	CID000102124
Drug	FK-316	CTRB2 CTRB1	1.81e-04	3	178	2	CID000133688
Drug	AC1L19T8	CTRB2 CTRB1	1.81e-04	3	178	2	CID000000694
Drug	Marinostatin D	CTRB2 CTRB1	1.81e-04	3	178	2	CID000132206
Drug	1FD7	CTRB2 CTRB1	1.81e-04	3	178	2	CID000445579
Drug	Glt-leu-phe-nh-meq	CTRB2 CTRB1	1.81e-04	3	178	2	CID000194914
Drug	AC1L4Z4F	CTRB2 CTRB1	1.81e-04	3	178	2	CID000194913
Drug	Glt-Phe-NH-FMeq	CTRB2 CTRB1	1.81e-04	3	178	2	CID000194912
Drug	diacetyl trimer	CTRB2 CTRB1	1.81e-04	3	178	2	CID000193527
Drug	FK-448	CTRB2 CTRB1	1.81e-04	3	178	2	CID006917869
Drug	Ac-Phe-OMe	CTRB2 CTRB1	1.81e-04	3	178	2	CID000097805
Drug	thiobenzyl N-heptafluorobutyrylanthranilate	CTRB2 CTRB1	1.81e-04	3	178	2	CID000133906
Disease	level of chymotrypsinogen B2 in blood serum	CTRB2 CTRB1	3.34e-05	2	171	2	OBA_2041192
Disease	X-linked congenital stationary night blindness	CACNA1F NYX	3.34e-05	2	171	2	cv:CN043584
Disease	congenital stationary night blindness (implicated_via_orthology)	CACNA1F NYX	3.34e-05	2	171	2	DOID:0050534 (implicated_via_orthology)
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	SEC16B WIPI1 TRPS1 KLF14 R3HDM2 GIPR ADRB1 PLCB3 TP53BP1	3.58e-05	276	171	9	EFO_0004612, EFO_0020943
Disease	phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement	SEC16B WIPI1 INPP5E TRPS1 KLF14 GIPR ADRB1 PLCB3 TP53BP1	8.11e-05	307	171	9	EFO_0004612, EFO_0020946
Disease	chymotrypsinogen B measurement	CTRB2 CTRB1	9.98e-05	3	171	2	EFO_0801477
Disease	systolic blood pressure, alcohol drinking	ZNF831 KIAA2013 LMAN1L ADRB1 RP1L1 LNX1	1.05e-04	128	171	6	EFO_0004329, EFO_0006335
Disease	Night blindness, congenital stationary	CACNA1F NYX CACNA2D4	1.22e-04	17	171	3	C0339535
Disease	Congenital stationary night blindness	CACNA1F NYX	1.99e-04	4	171	2	cv:C0339535
Disease	Ellis-Van Creveld Syndrome	EVC2 GLI1	1.99e-04	4	171	2	C0013903
Disease	Headache, HbA1c measurement	RTN4 PFKM GIPR	2.36e-04	21	171	3	EFO_0004541, HP_0002315
Disease	C-reactive protein measurement	AKAP6 DUSP12 TRAF3IP2 IL12RB1 SEC16B TRPS1 R3HDM2 SSPOP GIPR ZNF469 CILP2 SALL1 MROH6 SPHKAP RP1L1 TAF4 AFF4 TP53BP1	2.36e-04	1206	171	18	EFO_0004458
Disease	mean arterial pressure, alcohol consumption measurement	ZNF831 LMAN1L ADRB1 RP1L1	2.37e-04	52	171	4	EFO_0006340, EFO_0007878
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	SHROOM3 TRPS1 KLF14 R3HDM2 FGFBP3 PLCB3 TP53BP1	3.46e-04	224	171	7	EFO_0004530, EFO_0008317
Disease	free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	SEC16B WIPI1 TRPS1 KLF14 ADRB1 GLI1 PLCB3 TP53BP1	4.08e-04	303	171	8	EFO_0004612, EFO_0020945
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	TRPS1 KLF14 R3HDM2 FGFBP3 PLCB3 TP53BP1	4.28e-04	166	171	6	EFO_0004530, EFO_0004611
Disease	reticulocyte measurement	ATRN WIPI1 VWF TRPS1 KLF14 ZNF217 PFKM MAP3K5 ZNF469 NOL4L ADRB1 ZNF827 AKAP13 PLCB3 SIGLEC1 SPOCD1	4.36e-04	1053	171	16	EFO_0010700
Disease	triglyceride measurement, intermediate density lipoprotein measurement	SHROOM3 TRPS1 R3HDM2 FGFBP3 TP53BP1	4.81e-04	111	171	5	EFO_0004530, EFO_0008595
Disease	Bone Diseases, Developmental	ABL1 TRPS1 AFF4	5.05e-04	27	171	3	C0005941
Disease	Malignant neoplasm of breast	AKAP6 ABL1 VWF HDAC4 SHROOM2 PGR GGA3 MSH6 FASN PER2 GLI1 ICAM5 NHS SPOCD1 VPS13B TP53BP1	5.40e-04	1074	171	16	C0006142
Disease	HbA1c measurement	CACNA2D2 INPP5E KLF14 CTRB2 DAG1 R3HDM2 PFKM SHC3 NLRP6 GIPR PLCB3 CTRB1	6.03e-04	675	171	12	EFO_0004541
Disease	cortical thickness	AKAP6 HSPG2 SHROOM3 INPP5E TRPS1 CUL9 LMAN1L ZNF469 NOL4L COCH DLC1 SNAP91 NAV3 LNX1 RNF32-DT CRB2	7.89e-04	1113	171	16	EFO_0004840
Disease	Colorectal Carcinoma	AKAP6 EVC2 RTN4 AKAP3 ZNF217 PTPRU MSH6 HOXC9 DLC1 ICAM5 PLPPR2 TBX1	8.48e-04	702	171	12	C0009402
Disease	alkaline phosphatase measurement	WHRN SEC16B HSPG2 WIPI1 MRS2 NUMBL INPP5E CILP2 POM121 ZNF827 NFATC3 FGFBP3 RP1L1 AKAP13 TP53BP1	8.74e-04	1015	171	15	EFO_0004533
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	SHROOM3 KLF14 R3HDM2 PLCB3 TP53BP1	8.87e-04	127	171	5	EFO_0008595, EFO_0020947
Disease	colorectal adenoma	ZNF217 CCDC85A FAM193A	9.18e-04	33	171	3	EFO_0005406
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	SHROOM3 KLF14 R3HDM2 GIPR PLCB3 TP53BP1	1.13e-03	200	171	6	EFO_0004611, EFO_0020945
Disease	triglyceride measurement, high density lipoprotein cholesterol measurement	TRPS1 KLF14 R3HDM2 ADRB1 RP1L1 PLCB3 TP53BP1	1.13e-03	274	171	7	EFO_0004530, EFO_0004612
Disease	hepatocyte growth factor-like protein measurement	CACNA2D2 DAG1 RAD54L2	1.39e-03	38	171	3	EFO_0008154
Disease	dentate gyrus volume measurement	TRAF3IP2 TMEM219 LNX1	1.50e-03	39	171	3	EFO_0010083
Disease	free cholesterol measurement, very low density lipoprotein cholesterol measurement	TRPS1 KLF14 R3HDM2 ADRB1 PLCB3 TP53BP1	1.64e-03	215	171	6	EFO_0008317, EFO_0008591
Disease	follistatin measurement	R3HDM2 TP53BP1	1.77e-03	11	171	2	EFO_0010614
Disease	trypsin-2 measurement	CTRB2 CTRB1	1.77e-03	11	171	2	EFO_0008305
Disease	neuroticism measurement, cognitive function measurement	TMEM229A TMEM219 L3MBTL2 TRPS1 R3HDM2 PTPRU LHX8 CCDC85A FAM193A LNPK	1.79e-03	566	171	10	EFO_0007660, EFO_0008354
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	TRPS1 KLF14 R3HDM2 FGFBP3 PLCB3 TP53BP1	1.84e-03	220	171	6	EFO_0004529, EFO_0008317
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	SEC16B SHROOM3 KLF14 GIPR PLCB3 TP53BP1	1.92e-03	222	171	6	EFO_0008317, EFO_0020943
Disease	chronotype measurement	ALKBH4 HDAC4 CACNA2D2 INPP5E TRPS1 R3HDM2 NOL4L FAM193A PER2 NFATC3 HECW2 NAV3 ADAT2	1.97e-03	882	171	13	EFO_0008328
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	SEC16B KLF14 GIPR ADRB1 PLCB3 TP53BP1	2.06e-03	225	171	6	EFO_0008317, EFO_0020947
Disease	Night blindness, congenital stationary, type 1	CACNA1F NYX	2.12e-03	12	171	2	C3501847
Disease	Night Blindness, Congenital Stationary, Type 1A	CACNA1F NYX	2.12e-03	12	171	2	C3495587
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder)	CACNA1F NYX	2.12e-03	12	171	2	C1864877
Disease	mismatch repair cancer syndrome (is_implicated_in)	TAF1B MSH6	2.12e-03	12	171	2	DOID:0112182 (is_implicated_in)
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	CACNA1F NYX	2.12e-03	12	171	2	C1850362
Disease	X-Linked Csnb	CACNA1F NYX	2.12e-03	12	171	2	C3711543
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	CACNA1F NYX	2.12e-03	12	171	2	C1848172
Disease	Congenital Heart Defects	ABL1 TBX1 AFF4	2.13e-03	44	171	3	C0018798
Disease	FEV/FEC ratio	AKAP6 HSPG2 HDAC4 TRPS1 CTRB2 R3HDM2 SLCO5A1 NOL4L DLC1 CTRB1 LNX1 PLPPR2 RNF32-DT TBX1 CRB2 CD276	2.16e-03	1228	171	16	EFO_0004713
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	TRPS1 KLF14 R3HDM2 FGFBP3 PLCB3 TP53BP1	2.25e-03	229	171	6	EFO_0004639, EFO_0008317
Disease	IGFBP-1 measurement	MYO10 ZNF217	2.50e-03	13	171	2	EFO_0005118
Disease	Cone-rod synaptic disorder, congenital nonprogressive	CACNA1F NYX	2.50e-03	13	171	2	C4041558
Disease	systolic blood pressure, alcohol consumption measurement	LMAN1L ADRB1 RP1L1	2.57e-03	47	171	3	EFO_0006335, EFO_0007878
Disease	mean arterial pressure, alcohol drinking	ZNF831 LMAN1L ADRB1 RP1L1	2.58e-03	98	171	4	EFO_0004329, EFO_0006340
Disease	serum gamma-glutamyl transferase measurement	ATRN IL12RB1 SEC16B POM121 SALL1 ZNF827 RP1L1 AKAP13 SIGLEC1 CGNL1 TAF4 TP53BP1 CD276	2.68e-03	914	171	13	EFO_0004532
Disease	aspartate aminotransferase to alanine aminotransferase ratio	WHRN IL12RB1 ARHGAP39 CILP2 ZNF827 CD276	2.78e-03	239	171	6	EFO_0010934
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	WIPI1 KLF14 GIPR ADRB1 PLCB3 TP53BP1	2.78e-03	239	171	6	EFO_0008317, EFO_0020945
Disease	membranous glomerulonephritis (biomarker_via_orthology)	PTPRU MAP3K5	2.90e-03	14	171	2	DOID:10976 (biomarker_via_orthology)
Disease	Tourette syndrome	L3MBTL2 PTPRU CD276	3.07e-03	50	171	3	EFO_0004895
Disease	susceptibility to childhood ear infection measurement	ICAM5 HECW2 RNF32-DT VPS13B TBX1	3.27e-03	171	171	5	EFO_0007904
Disease	Body Weight	SEC16B GIPR	3.34e-03	15	171	2	C0005910
Disease	hemoglobin A1 measurement	TRPS1 KLF14 CTRB2 PFKM GIPR RP1L1 AKAP13 PLCB3 CTRB1	3.45e-03	520	171	9	EFO_0007629
Disease	apolipoprotein A 1 measurement, apolipoprotein B measurement	TRPS1 KLF14 R3HDM2 ADRB1	3.54e-03	107	171	4	EFO_0004614, EFO_0004615
Disease	hip circumference	SEC16B TRPS1 KLF14 GIPR FASN C4BPB PLPPR2	3.68e-03	338	171	7	EFO_0005093
Disease	anthranilic acid measurement	HDAC4 LNX1	3.80e-03	16	171	2	EFO_0010460
Disease	methylcobalamin deficiency type cblE, brain serotonin transporter measurement	VWF TRIO	3.80e-03	16	171	2	EFO_0004569, MONDO_0009354
Disease	very low density lipoprotein cholesterol measurement	TRPS1 KLF14 R3HDM2 FGFBP3 PLCB3 TP53BP1	4.19e-03	260	171	6	EFO_0008317
Disease	lysophosphatidylcholine 18:1 measurement	CCDC85A TAF4	4.29e-03	17	171	2	EFO_0010360
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	SEC16B KLF14 GIPR ADRB1 PLCB3 TP53BP1	4.52e-03	264	171	6	EFO_0008317, EFO_0020944
Disease	triglycerides in IDL measurement	TRPS1 FGFBP3 TP53BP1	4.67e-03	58	171	3	EFO_0022149
Disease	pyroglutamine measurement	ABL1 VWF DNPEP	4.67e-03	58	171	3	EFO_0005408
Disease	information processing speed, response to cranial radiation therapy	SEC16B CUL9 SIGLEC1	4.67e-03	58	171	3	EFO_0004363, EFO_0010950
Disease	Intellectual Disability	AKAP6 ZNF142 HDAC4 TRIO INPP5E LGI4 FASN LNPK	4.70e-03	447	171	8	C3714756
Disease	protein-glutamine gamma-glutamyltransferase e measurement	ZNF827 SIGLEC1 CD276	5.14e-03	60	171	3	EFO_0020690
Disease	glycoprotein measurement	TRPS1 DAG1 R3HDM2 TP53BP1	5.16e-03	119	171	4	EFO_0004555
Disease	sexual dimorphism measurement	SEC16B ZNF142 TMEM219 CACNA2D2 INPP5E RTN4 TRPS1 KLF14 RAD54L2 CIAO3 PLCB3 SPOCD1 TP53BP1 NPAS1	5.22e-03	1106	171	14	EFO_0021796
Disease	psoriasis	TRAF3IP2 TSC1 RUSC2 ICAM5 AKAP13 TNFAIP3	5.30e-03	273	171	6	EFO_0000676
Disease	osteochondrodysplasia (is_implicated_in)	HSPG2 TRPS1	5.35e-03	19	171	2	DOID:2256 (is_implicated_in)
Disease	unipolar depression, response to bupropion, mood disorder	BHLHE41 NAV3	5.35e-03	19	171	2	EFO_0003761, EFO_0004247, EFO_0006326
Disease	carotid artery disease (is_marker_for)	HSPG2 VWF	5.35e-03	19	171	2	DOID:3407 (is_marker_for)
Disease	type 1 diabetes mellitus (biomarker_via_orthology)	VWF ADRB1	5.35e-03	19	171	2	DOID:9744 (biomarker_via_orthology)
Disease	red blood cell density measurement	SHROOM3 TRPS1 R3HDM2 ZNF217 PFKM LMAN1L SALL1 ZNF827 AKAP13 PLCB3 CGNL1 VPS13B	5.39e-03	880	171	12	EFO_0007978
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	SHROOM3 R3HDM2 PLCB3 TP53BP1	5.47e-03	121	171	4	EFO_0008595, EFO_0020943

Protein segments in the cluster

Peptide	Gene	Start	Entry
SPGDSCPLAGSAVLE	AHRR	101	A9YTQ3
EAPGSLLLCSAPSAA	ALKBH4	196	Q9NXW9
AADSDSSLDEPCRPG	ADRB1	456	P08588
LPSADDDFPAGTLCA	CTRB2	141	Q6GPI1
LPALFDQTASAPCGG	MLLT6	676	P55198
PVASSETGPCTLGLD	BDP1	2206	A6H8Y1
APKPAASGACSVSAE	ADAT2	6	Q7Z6V5
PRAAASDVTCPTGGD	ASCL5	36	Q7RTU5
DTSDCGRGASFPPSL	CACNA2D2	1106	Q9NY47
LIDSCAGPGSLATEP	DNPEP	286	Q9ULA0
GAPSAAGSAAAPCLE	BHLHE41	191	Q9C0J9
DEEPSPTASCSLTGA	CSRNP2	291	Q9H175
EGPAATAAGAVCLPA	C2orf27A	146	P0DPF5
LGPAGCEADASAPAT	AGRN	886	O00468
ISVPNCAPAASSLDG	AKAP13	531	Q12802
SRPTAGQASEPAADC	AJM1	591	C9J069
AEGPAATAAGAVCLP	CDRT15P3	151	P0DPF6
AVLPSSPEACGAASL	IBA57	161	Q5T440
AAAEPPSGLACNGSF	GIPR	51	P48546
PVAAALDACSGNDPF	SNAP91	466	O60641
GTDATLRCSFSPEPG	CD276	261	Q5ZPR3
EELGSAGTSARCPPQ	RAD54L2	646	Q9Y4B4
PSNGSAPRVDCAFLD	ATP4B	191	P51164
GSAPTFCSDDEDVAP	FAM193A	286	P78312
SSPEGGCREVPQAAS	FAM90A10	231	A6NDY2
PSQPLDASASGDVSC	AFF4	301	Q9UHB7
PPGAGDSDSINALCT	NUMBL	351	Q9Y6R0
AGADCLASSVTPGPS	RNF32-DT	161	Q8NI28
AVCEESSTPFADGPL	R3HDM2	81	Q9Y2K5
GVSLPADCTGAVPAA	RANBP3	196	Q9H6Z4
ADCTGAVPAASPDTA	RANBP3	201	Q9H6Z4
CRAASGPGPEQEASF	HSPG2	2991	P98160
LCQATSATPTEGPGD	ARHGAP39	501	Q9C0H5
SSPEGGCREVPQAAS	FAM90A7	231	A6NKC0
PASVACEEASSPGPE	NPAS1	421	Q99742
ASIDASPALCAPSTG	LY6G6F	216	Q5SQ64
PDLPACSPASETGSE	NPAT	1311	Q14207
PQPSADQGSAELCGS	HECW2	556	Q9P2P5
DGACAAEPTSSGPAE	HECW2	681	Q9P2P5
AEEDPSPCASSGSGR	CACNA1F	276	O60840
ATAACRAQLSPAGDP	FAM189A1	441	O60320
PAPEAAAGSELALRC	FGFBP3	66	Q8TAT2
AAARPSGLVPDCSDF	HOXC9	36	P31274
DVTDSACSSAPGSGP	HDAC4	286	P56524
PAQEAATEGPSSACA	MAGED4	196	Q96JG8
DPDSCRGGSSVEAPC	KIAA1671	581	Q9BY89
RGGSSVEAPCPSDVT	KIAA1671	586	Q9BY89
TQSPEGGDPSVFCSL	GK3P	516	Q14409
DAPGSESPALACSTP	INPP5E	41	Q9NRR6
TPRSLDGSGSEPAVC	L3MBTL2	76	Q969R5
AGTVPSEPPSACASD	CRB2	31	Q5IJ48
SLNSGLTPSDPGEFC	LMAN1L	201	Q9HAT1
EPSDAGFCGILSEPS	ATRN	886	O75882
PEGPAQAAVASGCLT	KMT5B	496	Q4FZB7
SGAAEETGCVRPPAT	LANCL2	41	Q9NS86
SPDPGEVVSSACAAD	DAG1	171	Q14118
DPATSPCRIFDLGSD	FBXW5	271	Q969U6
SGPESLDCLAGPALA	PER2	696	O15055
PVSCTLDGLFPASEA	ICAM5	246	Q9UMF0
EGTPDTPACVVSLSG	PFKM	326	P08237
ASSCPAPLEGREAGQ	NAV3	576	Q8IVL0
LVCAYDPEAASAPGS	DCD	16	P81605
SSPAAAACAPLDSGA	MEX3D	566	Q86XN8
ALDVTSVGPPVAACG	MRS2	26	Q9HD23
GLIDSVCASDSPDRP	MYO10	1336	Q9HD67
RSGAGPESSTQDLPC	EVC2	66	Q86UK5
DGCPDGCASLTATAP	LNX1	146	Q8TBB1
AGDEDSCSSSAPLSP	LHX8	41	Q68G74
TAACGASDAPLLQPS	GGA3	436	Q9NZ52
PVGSDSTGLAPCLNA	GLI1	821	P08151
APGPLQAAECSLGSS	TUBGCP6	966	Q96RT7
RGATVPEAGSEPCSL	MROH6	71	A6NGR9
PSSSVAGENFPCEEG	FGD3	81	Q5JSP0
SGCPEDLTVGRAPTA	NOL4L	146	Q96MY1
APAAPTSCDFSPGDL	MSH6	81	P52701
TRAPGAASLLCAPDA	EN1	161	Q05925
SSPEGGCREVPQAAS	FAM90A19	231	P0DV76
DLADCSSLLGSDAPP	MCIDAS	81	D6RGH6
AELSSPDLESGCRAP	ITGB7	516	P26010
ETPAAGCTFEEASDP	PTPRU	21	Q92729
PCPESAGAATTEALS	POM121B	196	A6NF01
PDRFVTDQGACAGSP	PLPPR2	181	Q96GM1
PCASSTPVAVGDFPD	PGR	346	P06401
PPCPESAGAATTEAL	POM121	611	Q96HA1
PSSDSCPGLSNGEEV	PLCB3	511	Q01970
DLPGGSSPSEDSCLL	FAM189B	336	P81408
IPSCPGALTDLASSG	GATD1	91	Q8NB37
SEAAGALRPCPGASQ	GALR2	346	O43603
ELSCPGSATGDQVPF	SLC37A1	516	P57057
TAPGDLSATEPATCF	FBF1	516	Q8TES7
EEGSVSSACPVFGLP	FHIP1A	541	Q05DH4
PAESSCALPQEGSAG	FBH1	96	Q8NFZ0
ALTPESAPGCTTEFA	C16orf96	311	A6NNT2
ERCLAGTSFSENGPP	CGNL1	61	Q0VF96
AQDCGGASDTSASPP	CACNA2D4	1106	Q7Z3S7
TGPAACAASPADDGA	FRRS1L	21	Q9P0K9
ELQICPATAGSGPAA	ABL1	1096	P00519
CPDPVLVNGEFSSSG	C4BPB	81	P20851
AAAAAESCSPAPAGS	CCDC85A	11	Q96PX6
ATCSLTAPQDPDPAG	IL12RB1	381	P42701
PASGAAAVCAPESSS	KLF14	131	Q8TD94
SPELGAGDQSSPCAT	CUL9	276	Q8IWT3
DGRGSLAPLTSEPCS	FAM163A	71	Q96GL9
DPAPSALGSADLLVC	FASN	1301	P49327
PAGSEGAAPIAITCF	COCH	21	O43405
ATSCAAEAASPSGPL	DUSP4	336	Q13115
GPSDGCELSNPSASR	DUSP12	6	Q9UNI6
VLSSPAADCGPAGSA	SALL1	641	Q9NSC2
SDGPAESPVESCVSA	PPP4R1L	351	Q9P1A2
LPSADDDFPAGTLCA	CTRB1	141	P17538
EAAPCTDPFEAASGA	NLRP6	291	P59044
AGSPSGPDSSEDACE	CNST	381	Q6PJW8
SNATDSPCEGLPAAD	LRRN4	41	Q8WUT4
SPCEGLPAADATALT	LRRN4	46	Q8WUT4
AVFSCSGDGDPAPTV	LINGO4	431	Q6UY18
PSGPEVSSQGREASC	OLFML2A	381	Q68BL7
PCASPGSVAGLDLSQ	NYX	361	Q9GZU5
NVESAAAPGIGCPAA	MAP3K5	56	Q99683
PPAEFCLSPDGSSEA	RUSC2	971	Q8N2Y8
CEGDLSPGLTDSTAP	RPUSD2	431	Q8IZ73
ANAPDGAGSLPCTEL	RTN4	901	Q9NQC3
EGSAGSCAPVPAAAA	TAF4	131	O00268
CSVAPSGSLPPAAEA	SPHKAP	581	Q2M3C7
MSCSGSGADPEAAPA	TAF10	1	Q12962
AQGPASCAELSAPRG	SSPOP	3101	A2VEC9
AAAGCPEPLSTAEAP	TMEM229A	31	B2RXF0
DSALCEGSPDLPVSF	LGI4	36	Q8N135
GSQGAEALSPLSPCS	NHS	1566	Q6T4R5
SNSLPGDPASCSVLG	PLEKHG4	1096	Q58EX7
LSDVSCPPFLESGAE	TAF1B	151	Q53T94
SSPEGGCREVPQAAS	FAM90A9	231	A6NNJ1
VSECEGGSPPASQDS	SMG1	1896	Q96Q15
SSPEGGCREVPQAAS	FAM90A26	231	D6RGX4
SLNDLACAAVSPPAG	ARHGAP27	156	Q6ZUM4
ACAAVSPPAGLLGSS	ARHGAP27	161	Q6ZUM4
SPAESAAAGLTCLPS	SFT2D3	56	Q587I9
SRAAQGLPDPGAETC	RNF215	311	Q9Y6U7
SPTSGDANPAFGCVD	SLCO5A1	51	Q9H2Y9
LSGSCSAPSLAAPDG	SHC3	96	Q92529
SDCGSVLPLPGAQDT	POLR1H	21	Q9P1U0
PDDPSGFAVLASCAR	SHPK	26	Q9UHJ6
SPLCADSLGQEPGAA	SHROOM2	436	Q13796
AIGDSSVPSECPGTL	SHROOM3	1306	Q8TF72
SPSAEATVAGGCLLP	WHRN	691	Q9P202
GDSDSALDSVSPCPS	DLC1	931	Q96QB1
LSSEDDTSPGCAAPS	SPATC1L	96	Q9H0A9
APPSASCLGDAQLES	ARHGAP4	711	P98171
CSRNAAPDKAPGSGD	AKAP3	186	O75969
GEEPCFSSAPPNESA	AKAP6	2166	Q13023
GVGEELSSSPPSSCV	CLMN	681	Q96JQ2
LEPAPLDSLCSGASA	CIAO3	291	Q9H6Q4
PSGCSAVSEPASESV	TRAF3IP2	116	O43734
FDSAVTGPNGACLPA	CILP2	781	Q8IUL8
GEESCGASPTPATSA	C15orf39	981	Q6ZRI6
ALLASAPEAEGACPS	RECQL5	776	O94762
LAFSSPAAGGVCEPL	TRPS1	111	Q9UHF7
AFTPIDLPCGSADES	TSC1	551	Q92574
AFLAAPGTTSCPECG	ZNF444	171	Q8N0Y2
EGSCAAPESSPPASE	nan	131	Q6ZSR3
PSACEVVTGSPRGDS	VWF	2496	P04275
SGTFRSCPPEALGDL	TEP1	1531	Q99973
NPVATEDTAGLPGTC	NIBAN1	666	Q9BZQ8
SPDACSEGRSSEALP	RBMXL3	336	Q8N7X1
APAGCLSQAARTPGD	TNFAIP3	586	P21580
AASSAAAGEPLECPT	RNF208	131	Q9H0X6
EIGASPAAPCCSESG	RINT1	6	Q6NUQ1
EAGRASASAEPCPAE	RP1L1	1431	Q8IWN7
DGAESDASSCDPPPA	TBX2	316	Q13207
AAPADTCASSREPLG	SPOCD1	381	Q6ZMY3
GSLALGDPSSDPACS	SPOCD1	561	Q6ZMY3
EPTPSTGCSLDDNGV	VWCE	561	Q96DN2
SLCDPASFPPDGATV	NFATC3	996	Q12968
GRCPSDSSAEGASVP	PHF19	496	Q5T6S3
CLAELPTGAAASAPV	SIGLEC1	1511	Q9BZZ2
SPCESGDNTGEPSAL	TP53BP1	1701	Q12888
SGPESVSFELCSNPG	SEC16B	1001	Q96JE7
TGDSPAPSVGDLAAC	ZNF469	2071	Q96JG9
APSVGDLAACAPSPT	ZNF469	2076	Q96JG9
LSPGVSSLCDDDPGS	ZNF827	101	Q17R98
EASLPLTGSASCGVP	VXN	166	Q8TAG6
DSATFSICPGGEQPA	VPS13B	3141	Q7Z7G8
SVDGRQPGTCSPDLA	ZNF217	411	O75362
PPISCSEEGAGNATL	TMEM219	156	Q86XT9
SAAAEPEGPGASCAA	TBX1	81	O43435
GSPSPAEVEEGSCTL	ZNF142	681	P52746
ADAPPGGVESALSCF	WIPI1	6	Q5MNZ9
VRTEAAPCPGSAFAD	ZNF831	261	Q5JPB2
LPSTPCAEEAAAGGL	WDR86	151	Q86TI4
GANSCSPEGLLEPLA	ZMYM3	131	Q14202
NGPSSDSGVPEPAVC	TMEM266	336	Q2M3C6
TDRSPAAEGLVPCGS	TRIO	1701	O75962
SSPEGGCREVPQAAS	FAM90A18	231	P0DV75
EPGAAEPSACLEAAT	KIAA2013	56	Q8IYS2
AKECEPPSAGAAVTA	LNPK	146	Q9C0E8
ACGDCVTSPGAAEPA	NAF1	91	Q96HR8